SLC2A13-TERT Fusion FISH Probe
The SLC2A13-TERT Fusion FISH Probe is used to confirm a fusion of the SLC2A13 and TERT genes. The fusion of the SLC2A13 and TERT genes has been associated with Kidney Renal Clear Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
SLC2A13-TERT-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-RERE | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-REOR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-REGO | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-REGR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-REAQ | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-ORRE | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-OROR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-ORGO | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-ORAQ | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GORE | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GOOR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GOGO | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GOGR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GOAQ | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GRRE | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GROR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GRGO | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GRGR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-GRAQ | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-AQRE | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-AQOR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-AQGO | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-AQGR | 20 (40 μL) | 200 μL | ||
SLC2A13-TERT-20-AQAQ | 20 (40 μL) | 200 μL |
TERT Gene Summary
Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
Gene Name: Telomerase Reverse Transcriptase
Chromosome: CHR5: 1253286 -1295162
Locus: 5p15.33
SLC2A13 Gene Summary
The Solute Carrier Family 2 Member 13 (SLC2A13) gene is located on chr12 :40148822-40499661 at 12q12.
Gene Name: Solute Carrier Family 2 Member 13
Chromosome: CHR12: 40148822 -40499661
Locus: 12q12
Gene Diseases
The SLC2A13 TERT Fusion has been associated with the following diseases:
Disease Name |
---|
Kidney Renal Clear Cell Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|